MedTrace Logo

Cardioplegic Protection of the Heart

NCT07386990 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-02-12

No results posted yet for this study

Summary

This study seek to compare two different solutions used to protect the heart during cardiac surgery. 40 adult patients planned for coronary artery bypass surgery with cardiopulmonary bypass machine assistance will be included in the study. Blood samples from the first 48 hours after surgery will be analyzed together with physical data, x-ray-results, ecg and general outcome after surgery.

Conditions

  • Coronary Artery Bypass Graft (CABG)
  • Cardioplegia
  • Cardiopulmonary Bypass
  • Perioperative Myocardial Injury

Interventions

DRUG

Modified Buckberg cardioplegic solution

Study subjects randomized to this study group will receive Modified Buckberg cardioplegic solution during coronary artery bypass grafting operation.

DRUG

Modified St Thomas´ cardioplegic solution

Study subjects randomized to this study group will receive Modified St Thomas hospital´s cardioplegic solution during coronary artery bypass grafting operation.

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Snejana Hyllén, MD, Assistant Professor · Region Skåne

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2021-11-18
Completion
2025-04-29

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07386990 on ClinicalTrials.gov